Health care costs are climbing sharply for families, yet the political story coming out of Washington is about villains and saviors rather than spreadsheets. President Donald Trump is again casting big insurance companies as the main culprits behind your rising premiums, even as his own policies help shape those bills. The result is a familiar script in which insurers are the public face of pain that is also being driven by decisions made inside the White House.
Blaming insurers while premiums spike
President Donald Trump has spent the opening weeks of this year training public anger on health insurance companies, arguing that they are driving unaffordable premiums and skimping on care. In public remarks highlighted in recent coverage, Trump has portrayed large insurers as gatekeepers that deny treatment while collecting taxpayer subsidies, a message that resonates with patients who see denials and surprise bills far more often than they see federal rulemaking. Morning health policy briefings note that President Donald Trump is focusing blame on insurance companies for rising health care costs, reinforcing a narrative that your insurer, not his administration, is the primary obstacle to affordable coverage.
The political appeal is obvious, but the timing is striking. Analysts have already warned that Americans will pay significantly more for coverage this year, including for Medicare. On November 14, the Trump administration announced that Medicare Part B premiums will increase by 9.7 percent, the first time the standard Medicare premium has exceeded 200 dollars a month. That jump is the product of federal policy choices as well as medical inflation, yet the White House messaging keeps the spotlight squarely on private insurers.
What The Great Healthcare Plan actually does
The centerpiece of the president’s response is a sweeping proposal branded as The Great Healthcare Plan, which he has framed as a direct strike on insurance company profits. In an official Fact Sheet, President Donald Trump Calls on Congress to Enact The Great Healthcare Plan and argues that it will lower insurance premiums by stopping “big insurance companies” from receiving billions in extra taxpayer-funded subsidies. The same Fact Sheet describes a crackdown on what the administration calls opaque insurer practices, promising to redirect money “directly to the people” rather than to corporate balance sheets.
The White House website for Great Healthcare Plan repeats that promise, saying the initiative stops sending big insurance companies billions in extra taxpayer-funded subsidies and forces them to disclose prices and profits on their websites. Another section, labeled CALLING ON CONGRESS TO LOWER HEALTHCARE COSTS, casts President Donald as the champion of patients stuck with high deductibles and time consuming doctor’s visits. In a separate message, the White House notes that President Trump Announces The Great Healthcare Plan and quotes him telling Americans he is “thrilled” to lower healthcare prices and deliver the money directly to them, language that reinforces the idea that insurers have been hoarding public funds at patients’ expense.
Middlemen, PBMs and the new “bad guy”
Insurers are not the only industry in the administration’s crosshairs. The White House has also zeroed in on pharmacy benefit managers, the drug supply chain intermediaries that negotiate rebates between manufacturers and health plans. In its rollout of a health care affordability push, The White House said the plan “will end the kickbacks” paid by PBMs “to the large brokerage middlemen that deceptively raise the cost of prescription drugs,” promising that reforms to these arrangements will be part of the broader effort. A separate report from FOX notes that Inside Trump advisers have framed these pharmacy benefit manager payments as a key driver of high list prices, with Business correspondent Edward Lawrence reporting from the White Hou that the administration is even floating a threat to eliminate them completely.
The political logic is similar to the insurer narrative, casting “middlemen” as shadowy actors who inflate costs while adding little value. Critics of PBMs have long argued that these firms keep a share of manufacturer rebates rather than passing savings along to patients, a concern echoed in an analysis that likens the concept to a mainstay of commercial health insurance and warns that these middlemen have become notorious for capturing savings rather than passing it along to patients, as described in a piece on The Grinch who Stole Medicare. Yet while there is real money at stake in how PBMs operate, the administration’s focus on these actors again allows it to frame the problem as one of private sector greed rather than a more complicated mix of policy, pricing power and federal budgeting.
Inside the policy details and their limits
Beyond rhetoric, the administration has begun to sketch out how its health agenda would work in practice, and the details reveal both ambition and constraint. A budget watchdog’s review of the White House release on the Great Healthcare Plan notes that it would Codify Most Favored (MFN) prescription drug price deals, expand access to over the counter medications and authorize more telehealth, steps that could generate modest savings and cost reductions but fall short of a structural overhaul. Another analysis of the Great Healthcare Plan points out that one of its core ideas is to Fund Cost Sharing Reduction Program payments for marketplace plans, a move that would save taxpayers at least some money compared with the current workaround while still relying on private insurers to deliver coverage.
Supporters argue that these changes, combined with new transparency rules, will push insurers and drug companies to compete more aggressively on price. The official summary of Trump Calls on Congress to Enact The Great Healthcare Plan emphasizes “lowering insurance premiums” by changing how subsidies flow and by tightening rules around how insurers deny care. A separate policy overview notes that Amid
The gap between promises and pocketbook reality
Outside the administration, health policy analysts are drawing a much darker picture of what families will actually pay. One detailed review from an AUTHOR at a progressive think tank warns that Health care costs remain one of the top concerns for American families and that 2026 is shaping up to be one of the worst years yet, in part because temporary enhanced premium tax credits are set to expire. That analysis argues that if the enhanced tax credits are not extended, millions of people will see higher marketplace premiums, a change that would land on top of the Medicare Part B increase and other cost pressures. Another commentary bluntly concludes that American families are facing higher costs because of choices made by the Trump administration, not just because of insurer behavior.
Other critics are even more scathing about the president’s new plan. A coalition of patient advocates has labeled it a distraction, arguing that Trump is using a “joke” health care plan to divert attention from his Big Ugly Bill, which they say Rips health care away from over 15 million people and raises costs for those who remain insured. They argue that the new proposal promises higher costs and less care, not the other way around. A separate policy critique titled The Great Healthcare Plan Hoax underscores that while the administration touts its decision to Fund cost sharing reductions, it leaves intact a fragmented system in which insurers still design high deductible plans and post confusing information about routine care on their websites.
More From The Daily Overview
Nathaniel Cross focuses on retirement planning, employer benefits, and long-term income security. His writing covers pensions, social programs, investment vehicles, and strategies designed to protect financial independence later in life. At The Daily Overview, Nathaniel provides practical insight to help readers plan with confidence and foresight.
